Special Issues
Journal of Personalized Medicine publishes Special Issues to create collections of papers on specific topics, with the aim of building a community of authors and readers to discuss the latest research and develop new ideas and research directions. Special Issues are led by Guest Editors, who are experts on the topic and all Special Issue submissions follow MDPI's standard editorial process.
The journal’s Editor-in-Chief and/or designated Editorial Board Member will oversee Guest Editor appointments and Special Issue proposals, checking their content for relevance and ensuring the suitability of the material for the journal. The papers published in a Special Issue will be collected and displayed on a dedicated page of the journal’s website. Further information on MDPI's Special Issue polices and Guest Editor responsibilities can be found here. For any inquiries related to a Special Issue, please contact the Editorial Office.
Personalized Medicine in Gynecology and Obstetrics
Deadline: 20 October 2026
Plastic Surgery: New Perspectives and Innovative Techniques
Deadline: 20 October 2026
Inflammatory Bowel Disease (IBD): Diagnosis and Personalized Treatment
Deadline: 20 October 2026
Advances in the Use of Machine Learning for Personalized Medicine
Deadline: 25 October 2026
Advances in Oral Health: Innovative and Personalized Approaches
Deadline: 25 October 2026
Personalized Medicine and Management of Gynecologic Cancer
Deadline: 25 October 2026
Personalized Plastic and Reconstructive Surgery: Challenges and Prospects
Deadline: 25 October 2026
Bioinformatics and Data Analysis for Common Diseases: Advances in Precision Medicine
Deadline: 25 October 2026
Precision Medicine in Myocardial Infarction: Diagnosis, Prevention, and Treatment
Deadline: 25 October 2026
Obstetrics and Gynecology and Women's Health—2nd Edition
Deadline: 26 October 2026
Personalized Approaches in Spinal Deformity: Innovations in Diagnosis and Treatment
Deadline: 30 October 2026
Artificial Intelligence and Advanced Medical Imaging in Personalized Medicine
Deadline: 30 October 2026
of 17

